Norway: Observe Medical changes mind on Ferrari L purchase

Nordic medtech company, Observe Medical, has adjusted its short-term action plan, deciding to discontinue the process of acquiring Ferrari L, something that will reduce the company’s future funding needs and impact its run-rate target of NOK200-250m (US$18.8-23.5m) by year-end. The contemplated acquisition of Ferrari L was originally announced in December 2022. The decision to discontinue…

You must be a HMI Subscriber to view this content.

Subscribe Now »